Global Inhalation and Nasal Spray Generic Drugs Market to Reach $45.3 Billion by 2030
The global market for Inhalation and Nasal Spray Generic Drugs estimated at US$31.3 Billion in the year 2023, is expected to reach US$45.3 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Corticosteroids, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11 Billion by the end of the analysis period. Growth in the Bronchodilator segment is estimated at 5.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $9.5 Billion, While China is Forecast to Grow at 5.2% CAGR
The Inhalation and Nasal Spray Generic Drugs market in the U.S. is estimated at US$9.5 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$8 Billion by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook